03.10.2024 • NewsSK PharmtecoinvestmentSmall Molecules

SK Pharmteco to Expand Production in South Korea

South Korean contract development and manufacturing organization (CDMO) SK Pharmteco announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment to construct a new facility in Sejong, South Korea.

Scheduled to begin operations in late 2026, the new facility will be the fifth plant the company opens in South Korea. According to SK Pharmteco, it will span 135,800 square feet and feature eight production trains with an output of tens of metric tons annually. The investment also includes peptide R&D facilities, CGMP kilo labs, and CGMP pilot plant for peptide manufacturing. With these resources, SK Pharmteco said that it can support early-stage clinical and commercial production with great flexibility. SK Pharmteco plans to hire over 300 new employees at the Sejong site.

Another part of the investment is the construction of the shell for a sixth manufacturing plant, which will allow a quick expansion of capacity in the future.

Joerg Ahlgrimm, CEO of SK Pharmteco, said: “By investing in this new facility, we’re increasing our capacity in Asia in line with our global expansion strategy and solidifying our position as a trusted partner for companies developing groundbreaking treatments, demonstrating our adaptability and reliability in a rapidly changing industry.”

“Our new facility represents a significant investment in our future and a commitment to delivering exceptional value to our customers,” said Yongwoo Park, SK Pharmteco’s president, Small Molecule, Asia. “By expanding our capacity and capabilities, we can offer even faster turnaround times, increased flexibility, and a higher level of quality.”

SK Pharmteco’s current site in Sejong, South Korea. © SK Pharmteco
SK Pharmteco’s current site in Sejong, South Korea. © SK Pharmteco

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.